NCT06995742 (ANNE One TMRCT) is a NA clinical trial of Device Array Use in Vital Sign Evaluation, sponsored by Northwestern University.

Who is sponsoring NCT06995742?

NCT06995742 is sponsored by Northwestern University.

What drugs are being tested in NCT06995742?

Interventions in NCT06995742: Device Array Use, Routine Vital Sign Measurement.

What condition does NCT06995742 study?

NCT06995742 studies Vital Sign Evaluation, Vital Sign Monitoring, Sleep Quality, Provider Behavior, Patient Satisfaction.

Is NCT06995742 still recruiting?

NCT06995742 is currently recruiting now. Last updated 5 June 2025.

Last reviewed 2025-06-05 · How we verify

NCT06995742: ANNE One TMRCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of ANNE One-Wellue Device Array Use on Staff Bedside Vital Sign Measurement Activity

Recruiting now NA Last updated 5 June 2025

What this trial tests

NA trial testing Device Array Use in Vital Sign Evaluation in 270 participants. Currently enrolling.

Timeline

2 June 2025

Primary endpoint
31 July 2026

31 July 2026

Quick facts

Lead sponsor	Northwestern University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	270
Start date	2 June 2025
Primary completion	31 July 2026
Estimated completion	31 July 2026
Sites	2 locations across United States

Drugs / interventions tested

Device Array Use
Routine Vital Sign Measurement

Conditions studied

Vital Sign Evaluation — all drugs for Vital Sign Evaluation →
Vital Sign Monitoring — all drugs for Vital Sign Monitoring →
Sleep Quality — all drugs for Sleep Quality →
Provider Behavior — all drugs for Provider Behavior →

Sponsor

Northwestern University

Who can join

18 and older, any sex, with Vital Sign Evaluation or Vital Sign Monitoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized controlled trial of a time motion study of time spent obtaining and charting vital signs for inpatients, comparing use of a wireless Bluetooth vital sign array as intervention versus routine vital sign obtainment activity on a general medical floor.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Northwestern University trials

Trials by the same sponsor.

NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06995742 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Northwestern University
Last refreshed: 5 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06995742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing